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Chromatographic protein and peptide separation technologies enable comprehensive pro-
teomic analysis of plasma and other complex biological samples by mass spectrometry.
However, as the number of separations and/or fractions increases, so does the number of
peptides split across fraction boundaries. Irreproducibility of peptide chromatographic sepa-
ration results in peptides on or near the boundary moving partially or entirely into adjacent
fractions. Peptide shifting across fraction boundaries increases the variability of measured
peptide abundance, and so there is a trade-off between proteomic comprehensiveness using
separation technologies and accurate quantitative proteomic measurements. In this paper, a
method for detecting and correcting split peptides, called Peptide Shifter, is introduced and
evaluated. An essential component of Peptide Shifter is a global peptide expression profile
analysis that allows the inference of the underlying peptide shift pattern without the use of
peptide labeling or internal standards. A controlled proteomic analysis of plasma samples
demonstrates a 34% decrease in peptide intensity variability after the application of Peptide
Shifter. (J Am Soc Mass Spectrom 2007, 18, 1638–1645) © 2007 American Society for Mass
SpectrometryThe chromatographic separation of biological sam-ples into discrete fractions has become an essen-tial component in the toolbox of proteomic tech-
niques for reducing sample complexity. This is
illustrated by the HUPO (Human Proteome Organiza-
tion) Plasma Proteome Project’s (PPP) endeavor to
catalogue all the known plasma proteins. Eighteen
laboratories participated in the PPP, resulting in over
3000 high-confidence protein identifications [1, 2]. More
than 200 protein identifications were generated per
sample using multidimensional peptide or protein sep-
aration (e.g., SCX-RPLC-MS) before analysis by mass
spectrometry [3]. In contrast, laboratories using one-
dimensional peptide separation (RPLC-MS) identified
significantly fewer proteins. Almost all participating
laboratories used some form of protein and/or peptide
separation, which illustrates the wide adoption of sep-
aration technologies in proteomics. The advantages of
sample simplification are the same for biomarker dis-
covery studies. Such studies rely on the accuracy of
expression profiling and therefore require reproducible
sample separation techniques.
Proteomic expression profiling is the comparative
analysis of samples to discover differentially expressed
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doi:10.1016/j.jasms.2007.06.003proteins among healthy, diseased, or drug-treated pop-
ulations. Proteomic expression profiling technologies
rely on a variety of labeled [4 – 6] and unlabeled ap-
proaches [7–11], where accuracy is enabled by low
analytical variability and comprehensiveness is enabled
by the extent of separation [12, 13]. Separation technol-
ogies that collect fractions in discrete aliquots for sub-
sequent mass spectrometric analysis result in some
peptides that elute across multiple fractions. Moreover,
as the number of fractions increases, so does the num-
ber of peptides contiguously eluting through consecu-
tive fractions [14 –16]. We refer to these peptides as split
peptides.
As with all methods that transform continuous
into discrete signal, there is generally a loss of
information in the fractionation process analogous to
monitoring chromatography profiles at low sampling
rates [17]. This loss of information is illustrated in
Figure 1. A peptide completely eluting in one fraction
is an unsplit peptide whose elution volume is above
the detection limit of a detector. If a peptide is split
into two sufficiently large volumes, signal will be
detected in both fractions. However, if the split
peptide volumes appear at the level below the limit of
detection in one of the fractions, then the determina-
tion of peptide amount is underestimated (partially
degenerate split peptide). Finally, if both split pep-
tide volumes are below the level of detection in both
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information. Thus, irreproducible splitting of pep-
tides arising from irreproducible separation and/or
fractionation ultimately increases the variability in
peptide abundance measurements, and thus de-
grades the accuracy of expression profiling. The
influence of the chromatographic retention time (RT)
reproducibility in the first dimension on the repro-
ducibility of MS intensities has, up to now, not
received sufficient attention. Based on our experi-
ence, the largest inter-run RT shifts observed in our
strong cation-exchange (SCX) system vary within 6 s.
Figure 1. The taxonomy of split peptides. In the Separation
Profile pane, the vertical line represents a separation boundary
between adjacent chromatographic fractions. In the LC-MS Inten-
sity pane, the horizontal line is the limit of detection. Four types of
split peptides are shown (a–d). Peptides that are not split across
the boundary fully elute in one fraction (a). Peptides that are
split across adjoining fractions and detected by LC-MS in both
are called split peptides (b). Partially degenerate split peptides
are split across fractions but are below the level of detection in
one of the fractions (c). Fully degenerate split peptides are split
across fractions but are below the level of detection in both
fractions (d).
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peptides affected by RT shifts at the end of the
fraction, for a total of 20% of peptides affected.
Therefore it is of practical interest to estimate the
influence of these RT shift values on the reproduc-
ibility of RPLC-MS profiles.
In expression profiling studies, many biological
replicates are analyzed [14], and processing parame-
ters are held constant from replicate to replicate to
minimize bias. If separation is performed, aliquots of
all samples are collected at fixed time points for
subsequent mass spectrometric analysis. Variability
in fractionation from sample to sample results in
differential peptide splitting across samples in the
study. We refer to this as fraction shift and the
relative magnitude and direction of fraction shift
across samples as the fraction shift profile. These
concepts are illustrated in Figure 2. Ideally, split
peptides could be detected and then corrected to
reduce or eliminate fraction shifting. The most
straightforward and accurate approach for the detec-
tion and correction of fraction shift would be the use
of internal standards, such as isotope-labeled pep-
tides [10]. However, the application of such a method
incurs increased costs, sample handling, limits on the
number of samples analyzed, and sample complexity
[3]. This paper introduces Peptide Shifter, a method
for reliable detection and correction of split peptides
across samples without the use of internal standards.
The method uses a robust technique for inferring the
fraction shift profile across samples in a study. A
controlled experiment using human plasma samples
was performed to measure the impact of fraction shift-
ing on analytical variability and the ability of Peptide
Shifter to detect and correct this variability.
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Sample Preparation
Pooled human plasma samples were depleted using
MARS (Agilent Technologies, Palo Alto, CA) and di-
gested with Lys-C/Trypsin. After digestion, samples
were desalted on HP1100 chromatograph (Agilent
Technologies) using C18 guard cartridge (Phenomenex,
Torrance, CA). Samples were pooled together and
freeze-dried. For strong cation-exchange (SCX) chroma-
tography buffers used for the study consisted of 15%
acetonitrile and 5 or 1000 mM ammonium formate (pH
3.15 by formic acid) for Buffers A and B, respectively.
The stability of the gradient and buffers over the course
of six SCX runs was ensured by monitoring the reten-
tion time (RT) of standards. Inter-run RT shifts ob-
served in this experiment were random and did not
exceed 0.5 s. Samples were dissolved in SCX buffer A
and distributed into six aliquots of equal volumes for
SCX chromatography. Ninety percent of the volume of
each aliquot was injected and separated at 0.8 mL/min
flow rate using a strong cation exchange 4.6  150 mm,
5 m Biobasic SCX-300 column (Thermo Fisher Scien-
tific, Waltham, MA). The gradient consisted of three
linear slopes: 30 to 80 mM for 6 min, 80 to 150 mM for
4 min, 150 to 750 mM for 4 min, followed by isocratic
gradient at 750 mM for 2 min.
Each lyophilized SCX fraction was re-solubilized
in 90/10 water/acetonitrile, 0.2% trifluoroacetic acid
(TFA) before LC-MS analysis. The reversed-phase (RP)
LC-MS system consisted of a CapLC pump and a
Q-TOF Ultima mass spectrometer (Waters MicroMass
UK, Manchester, UK). Peptide separation was achieved
using a home-packed Jupiter 300 C18 column (150 m 
10 cm, stationary phase from Phenomenex). A linear
gradient of 10–40% acetonitrile (0.2% formic acid) in 65
min was executed at a flow rate of 12.5 L/min.
Experimental Design
An uninterrupted sequence of six runs with fraction-
ation (eight unequal fractions covered the range of 13
min) was executed. To mimic RT shifts the fraction
collection was shifted uniformly (so neither the length
of individual fractions nor the total length of fraction-
ation was changed). Therefore, the second triplet of
samples (Group 2) was run with the same gradient, but
the fractionation was shifted 12 s toward the beginning
of the run comparatively to the first triplet (designated
as Group 1). The fractionation rather than the gradient
was shifted to simplify the execution and analysis of the
experiment. The maximum RT variations were 1 s.
Peptide Detection
The LC-MS data were smoothed in both the m/z and
retention time dimensions, baseline subtracted, and
centroided. An isotopic model was applied to all localmaxima to determine the monoisotopic peaks. For each
resulting peak m/z, retention time, charge, and intensity
were reported.
Normalization and Clustering
To minimize analytic variability caused by LC-MS
analysis, the three dimensions of LC-MS data (mass,
retention time, intensity) were normalized. For each
fraction, a standard sample was selected and all other
samples aligned to it on mass and retention time
coordinates. A dynamic and nonlinear algorithm was
used to correct the retention time domain of each
sample to the standard sample. After the correction of
retention times, all pairs of aligned peptides were used
to derive a normalization factor to adjust sample inten-
sities to the standard sample intensity domain. Peptides
were then clustered on similar mass and retention time
using standard hierarchical clustering methods. For
each peptide cluster, a median mass and retention time
were used to represent peptides in the cluster. This
results in regression to the norm, further increasing the
accuracy of mass and retention time. Normalized pep-
tide clusters reproducibly matched in three or more
runs out of six were selected for the analysis. This level
of reproducibility is routinely applied to eliminate
low-confidence peptides.
Detection of Nondegenerate Split Peptides
Pairs of peptide clusters from adjoining fractions are
matched that have the same m/z, retention time, and
charge values. Matching tolerances for m/z and reten-
tion time were set to 0.1 Da and 1 min, respectively.
Furthermore, the expression profiles of the peptide
cluster pairs must be negatively correlated with Pearson
correlation coefficient less than 0.20.
Detection of Degenerate Split Peptides
By definition, a degenerate split peptide is not detected
in adjoining fractions, and thus the fraction shift profile
(which is the fingerprint of split peptides) is found first
and then putative degenerate split peptides are corre-
lated to the fraction shift profile. We describe both a
supervised and an unsupervised method for determin-
ing the fraction shift profile. The unsupervised method
uses high-confidence split peptides to define the frac-
tion shift profile. First, all pairs of peptide clusters in
adjoining fractions that match on m/z, retention, and
charge (0.1 Da and 1 min matching tolerances) are
found. Furthermore, these peptide clusters were re-
quired to be highly reproducible (found in all six
samples) and be strongly and negatively correlated
with Pearson score below 0.75. From these peptide
clusters a consensus expression profile is obtained by
taking the median normalized intensity value in each
sample. This consensus expression profile becomes the
fraction shift profile.
1641J Am Soc Mass Spectrom 2007, 18, 1638–1645 PEPTIDE SHIFTER: ENHANCING SEPARATION REPRODUCIBILITYThe supervised method applies hierarchical cluster-
ing with average linkage and Spearman correlation to
all normalized peptide cluster expression profiles in a
fraction. The most prevalent expression profiles are
reported for each fraction along with their median
consensus profile. The most common consensus expres-
sion profile across all fractions is selected as the fraction
shift profile.
Normally, the supervised method for finding the
fraction shift profile is used. However, if the investiga-
tor has auxiliary data such as UV profile data from the
SCX separation runs then these can be combined with
the supervised or unsupervised method to enhance
confidence in the fraction shift profile.
Once the fraction shift profile has been determined,
all peptide clusters highly correlated to the fraction shift
profile are selected. Specifically, peptide clusters with a
Pearson correlation score above 0.70 or below 0.70 are
selected.
Correction of Peptide Intensities
The expression profiles for matched nondegenerate
split peptides from adjoining fractions were added
together to form the new integrated profile. Expression
profiles for each degenerate split peptide were added to
the fraction shift profile pattern (normalized to the
median intensity of the degenerate split peptide). The
new integrated profiles replace the original profiles.
Data Management
All data are captured in a peptide database where each
peptide is defined along the following dimensions. A
study consists of replicates grouped into conditions. For
example, the fraction shift experiment has two condi-
tions (“No Shift” and “Shifted”) and three replicates in
each condition. Each peptide cluster found in a study is
assigned a unique cluster identifier. Furthermore, each
member of a peptide cluster has an observed fraction,
m/z, retention time, charge, and intensity. Peptide
cluster updates such as expression profile corrections
are tracked in the database.
Results and Discussion
In the fraction shift experiment, each peptide cluster
was classified as being nonsplit, split, or degenerate
using supervised fraction shift analysis. Out of 27,288
peptide clusters, a total of 20% were affected by the
forced fraction shift of 12 s: 2% of peptides were split
peptides and 18% were degenerate (either totally or
partially) split peptides. The larger number of degener-
ate split peptides is consistent with expectations for two
reasons. First, the SCX elution profile of a peptide has a
long tail to the right (see Figure 1), and thus the fraction
boundary will likely intersect the tail of a peptide’s
elution profile. Furthermore, if the fraction boundary
intersects the tail of a peptide’s elution profile, thenlikely the resulting LC-MS peptide intensity measure-
ment for the tail portion will be below the LC-MS
detection limit. Second, approximately half of all pep-
tides have intensity less than threefold the LC-MS
detection limit. Low-intensity peptides are frequently
degenerate because, when they are split, at least one of
the halves is likely to be below the LC-MS detection
limit. The combination of these two factors increases the
number of degenerate split peptides above nondegen-
erate split peptides.
Examples of peptides detected and corrected by
Peptide Shifter appear in Figure 3. In the top left panel
of Figure 3, an example of a nondegenerate split peptide
is shown. Notice how the peptide profiles of the matched
peptide clusters are mirror images of each other. An
example of a partially degenerate split peptide located
on the border between Fractions 1 and 2 can be seen in
the lower right panel of Figure 3. This peptide was
detected in Fraction 1 only before fraction shift and
detected in Fraction 2 only after the fraction shift.
Despite being partially degenerate, the total peptide
intensity has low variability.
To quantify the improvement of split peptide correc-
tion, the coefficient of variation (CV) of peptide inten-
sity before and after correction was determined for split
peptides and for all peptides. For the set of peptides
identified as split peptides, the CV of peptide intensity
before correction was 32% and after correction was 16%.
For the set of peptides identified as degenerate split
peptides, the CV of peptide intensity before correction
was 40% and after correction decreased to 14%. These
values agree with the CV of peptide intensities of
technical LC-MS repeats (14%) that is obtained for
nonshifted samples (data not shown). In addition, the
analysis of the intensity variability for all peptides
shows that the CV decreases from 29 to 19% after
fraction shift correction. Thus, Peptide Shifter reduces
overall peptide intensity variability by 34%.
Intensities of split peptides are negatively correlated
as can be seen in Figure 4. Peptides randomly selected
from adjacent fractions had their expression profiles
correlated. Because these peptides are not biased to
being split peptides, their Pearson correlation scores are
centered around zero, as seen in the distribution on the
left. Pairs of peptide clusters matched between adjoin-
ing fractions on m/z, retention time, and charge (thus
biased to being split peptides) have a negatively
skewed distribution of Pearson correlation scores. This
analysis supports the approach of using expression
profile correlation to detect split peptides.
The supervised learning method was applied to all
eight fractions of all six SCX runs. The resulting fraction
shift profiles were clustered into the six most frequently
occurring patterns (depicted in Figure 5). The upper
panel on the left demonstrates a pattern where peptide
intensities reproducibly increase in the shifted runs. The
inverse pattern can be seen in the middle upper panel.
These two shift patterns correspond to peptides shifting
in and shifting out of Fraction 2 because of their
1642 SITNIKOV ET AL. J Am Soc Mass Spectrom 2007, 18, 1638–1645Figure 3. Examples of detection and correction of split peptide. The red and blue expression profiles
correspond to a pair of matched peptides from Fractions 1 and 2, respectively. The corrected profile
appears in black. As expected, there is an intensity differential between the first three replicates (Group 1,
no shift applied) and the last three replicates (Group 2, controlled shift) due to peptide splitting.Figure 4. Distribution of correlation coefficients of peptides from adjacent fractions. In both
distributions peptides are selected from adjoining fractions. On the left, peptide pairs are selected
randomly, whereas on the right peptides are matched on m/z, retention time and charge. The
distribution on the right is biased to negatively correlated peptides.
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from Fraction 1 and leaving from Fraction 2 to Fraction
3 were similar and correlate. Consequently, the super-
vised approach determined the expected fraction shift
profile.
The correlation of relative changes in intensities of
peptides on opposite borders is illustrated in Figure 6,
which depicts the results of hierarchical clustering of all
Fraction 2 peptides using average linkage and Spear-
man correlation. Expression profiles for peptides lo-
cated at the front border of fraction two (upper left, blue
box) are highly positively correlated (i.e., green). Simi-
larly, expression profiles for peptides located at the
back border of fraction two (lower right, blue box) are
positively correlated. Consequently, split peptides are
among the most positively correlated peptides. Further-
more, those peptides shifted into Fraction 2 and those
shifted out of Fraction 2 are strongly negatively corre-
lated (upper right and lower left, yellow boxes), as
expected.
Unsupervised learning, as defined in the Experimen-
tal section, selected 65 peptides, and these are depicted
in Figure 7. The expression profiles of these 65 peptides
share the pattern consistent with the design of the
fraction shift experiment. Note that it is advisable to
apply the supervised and unsupervised methodologies
in parallel to boost confidence in the determination of
the fraction shift pattern. In this analysis, the two
methods yield the same result.
To confirm the ability of Peptide Shifter to detect
fraction shifts in the context of a real study, it was
applied to the proteomic analysis of 104 human plasma
samples fractionated by SCX over 6 consecutive days
(Figure 8). The Generation of Fraction Shift Profile was
based on 273 peptides using the unsupervised Peptide
Shifter method. Twenty randomized permutation tests
were applied to the LC-MS intensity data to estimate
the probability that these 273 peptides could be ob-
tained by chance alone. The 20 permutation tests aver-
Figure 7. Expression profile derived from the 65 peptides with
the most negatively correlated matches in adjoining bands. The
horizontal axis are three replicates of Group 1 followed by the
three replicates of Group 2.aged 18 peptides, resulting in a false positive rate of 7%.
Because this was a large-scale proteomic study, several
aspects of fraction shifting are apparent that could not
be seen in the controlled study on six samples. First, the
downward trending of the profile is evident (Figure 8).
A linear fit for this trending was obtained and cali-
brated against UV profiles for the SCX runs to establish
an absolute scale for fraction shift in seconds (y-axis).
The magnitude of the largest fraction shift over the 104
SCX runs was about 6 s. This enables quantification of
between-run variability as well as between-day vari-
ability. The downward trending is likely the result of
column aging. Also apparent is that Day 2 and Day 6
had different behaviors than did the other days, indi-
cating that there are other factors contributing to frac-
tion shifting. Peptide Shifter determined that 3313 out
of 44,070 (7.5%) peptides were split. Median CV for
nonsplit and split peptides was estimated as 38 and
54%, respectively. After normalization of split peptides,
their median CV was decreased to 41%.
Conclusion
For the SCX gradient presented here, Peptide Shifter
reduces peptide intensity variation by detecting and
correcting split peptides. Overall, peptide intensity
variability was reduced 34%. Peptides identified as
being split had peptide intensity variability reduced
by 64%.
In addition to reducing peptide intensity variability,
Peptide Shifter provides diagnostic information through-
out the gradient of the separation run. Although the
fraction shift profile discovered in this experiment was
consistent from fraction to fraction (by design of the
experiment), Peptide Shifter detects the fraction shift
profile on a per fraction basis. Thus, nonuniform frac-
tion shifts can be detected and corrected using Peptide
Figure 8. Fraction shift profile analysis of a study consisting of
104 plasma samples. The samples were processed sequentially by
SCX over 6 days resulting in 8 fractions per sample. Each sample
fraction was then analyzed by LC-MS using the same protocols
described in the Experimental section. Peptide Shifter was applied
to this dataset to first determine the Fraction Shift Profile and then
to detect split peptides.Shifter as well as the uniform fraction shift analyzed
1645J Am Soc Mass Spectrom 2007, 18, 1638–1645 PEPTIDE SHIFTER: ENHANCING SEPARATION REPRODUCIBILITYherein. Peptide Shifter also enables the diagnosis and
quantification of column aging and the identification of
outlier SCX runs.
The limits of Peptide Shifter have not been com-
pletely examined. In particular, the performance of
Peptide Shifter as the number of fractions increases is
unknown. There are at least two issues to be addressed
as the number of fractions increases. First, as the num-
ber of fractions increases, the number of peptides split
across three or more fractions also increases. Peptide
Shifter can be extended to detect and correct these
peptides. Specifically, peptide matching can be per-
formed across multiple contiguous fractions to deter-
mine the start and end fractions of a peptide’s elution.
Negative correlation and fraction shift learning tech-
niques still apply. Second, as the number of fractions
increases, the number of low-intensity peptides in-
creases disproportionately. Thus, the relative propor-
tion of degenerate split peptides to nondegenerate split
peptides will increase. The performance of Peptide
Shifter under these conditions is unknown.
It is important to note that confident detection and
correction of partially degenerate split peptides will
decrease if the number of samples is very small (i.e.,
four or fewer). We plan to extend the utility of Peptide
Shifter to make it applicable to very small studies.
Peptide Shifter has been successfully applied to
several in-house clinical studies where the large num-
ber of samples required, for example, multiple columns,
multiple days of processing, multiple operators, and
multiple batches of buffer. These results will be the
subject of a subsequent publication.
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